Abstract
CEA was extracted by the perchloric acid method from primary adenocarcinomas of the colon and the ovary, from ascitic and pleural fluids from patients with pancreatic, lung and breast cancer, and from the cyst fluid of a benign ovarian cystadenoma. Further purification included gel filtration and affinity chromatography. Antisera against CEA from colon, breast, ovary, lung and pancreatic cancer were produced in rabbits. In double diffusion experiments, all these CEA samples showed a reaction of complete immunological identity with all the anti-CEA sera, whatever their origin. CEA from colon, breast, pancreas and ovary were labelled with 125I and used in radioimmunological experiments. In a radioimmunological system where the tracer and the antiserum were constant, all the CEA used as standards gave parallel inhibition curves, having nearly identical slopes. This was another criterion of immunological identity. Sera of numerous cancer patients were assayed in several RIA systems, one of them being the classical system with colonic CEA as tracer and anti-colonic CEA as antiserum, the others being "organ specific" systems. The values obtained in these assays were found to be highly correlated: the rank coefficient of correlation between colonic and breast cancer RIA systems was rs = 0.96, that between colonic and ovarian RIA systems, 0.92, that between colonic and pancreatic RIA systems, 0.97 and that between colonic and lung RIA systems 0.96. It is thus concluded that by use of different organ-derived CEA preparations and their corresponding polyclonal antisera, no significative differences in serum CEA levels may be expected. No evidence of organ specificity of serum CEA was found.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- De Young N. J., Ashman L. K. Physicochemical and immunochemical properties of carcinoembryonic antigen (CEA) from different tumour sources. Aust J Exp Biol Med Sci. 1978 Jun;56(3):321–331. doi: 10.1038/icb.1978.34. [DOI] [PubMed] [Google Scholar]
- Egan M. L., Pritchard D. G., Todd C. W., Go V. L. Isolation and immunochemical and chemical characterization of carcinoembryonic antigen-like substances in colon lavages of healthy individuals. Cancer Res. 1977 Aug;37(8 Pt 1):2638–2643. [PubMed] [Google Scholar]
- Fritsche R., Mach J. P. Isolation and characterization of carcinoembryonic antigen (CEA) extracted from normal human colon mucosa. Immunochemistry. 1977 Feb;14(2):119–127. doi: 10.1016/0019-2791(77)90290-7. [DOI] [PubMed] [Google Scholar]
- Gold P., Freedman S. O. Specific carcinoembryonic antigens of the human digestive system. J Exp Med. 1965 Sep 1;122(3):467–481. doi: 10.1084/jem.122.3.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
- Hijmans W., Schuit H. R., Klein F. An immunofluorescence procedure for the detection of intracellular immunoglobulins. Clin Exp Immunol. 1969 Apr;4(4):457–472. [PMC free article] [PubMed] [Google Scholar]
- Hill R., Daunter B., Khoo S. K., Mackay E. V. Nature of carcinoembryonic antigen purified from malignant ascitic fluid of serous cystadenocarcinoma of the ovary. Mol Immunol. 1981 Jul;18(7):647–653. doi: 10.1016/0161-5890(81)90036-5. [DOI] [PubMed] [Google Scholar]
- Krupey J., Wilson T., Freedman S. O., Gold P. The preparation of purified carcinoembryonic antigen of the human digestive system from large quantities of tumor tissue. Immunochemistry. 1972 Jun;9(6):617–622. doi: 10.1016/0019-2791(72)90247-9. [DOI] [PubMed] [Google Scholar]
- Pusztaszeri G., Mach J. P. Carcinoembryonic antigen (CEA) in non digestive cancerous and normal tissues. Immunochemistry. 1973 Mar;10(3):197–204. doi: 10.1016/0019-2791(73)90008-6. [DOI] [PubMed] [Google Scholar]
- Santen R. J., Collette J., Franchimont P. Partial purification of carcinoembryonic-reactive antigen from breast neoplasms using lectin and antibody affinity chromatography. Cancer Res. 1980 Apr;40(4):1181–1188. [PubMed] [Google Scholar]